The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

Table 5 Univariate and multivariate logistic regression analyses for the uccurence of grade 4 neutropenia

Factors	Number (%)	Univariate		Multivariate
Factors	Number (%)	Odds ratio (95% CI)	P	Odds ratio (95% CI)	P
Age (y) > 70	58 (49%)	1.45 (0.68–3.09)	0.340	1.99 (0.85–4.64)	0.113
PS ≥ 1	62 (53%)	0.55 (0.26–1.18)	0.126	0.71 (0.30–1.66)	0.425
DTX cycle< 10	72 (61%)	0.56 (0.26–1.12)	0.146	0.53 (0.22–1.25)	0.148
PEG GCSF use	97 (82%)	0.73 (0.27–2.02)	0.548	0.94 (0.28–3.18)	0.916
Low initial CBZ dose	81 (69%)	0.21 (0.08–0.52)	< 0.001*	0.21 (0.08–0.59)	0.002*

ISSN: 1471-2407